Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,796 total articles
Applied Materials, Inc., a leading provider in materials engineering solutions for the semiconductor and advanced display industries, announced it will report its fiscal second quarter 2026 financial results on May 14, 2026. The earnings conference call will be webcast live, allowing investors and analysts to receive updated financial and operation…
Kelly Services, Inc., a global specialty talent solutions provider, plans to announce its Q1 2026 financial results before market open on May 7, 2026. The company will accompany the release with a financial presentation and a live webcast conference call to discuss the quarterly performance and address analyst questions.
Dragonfly Energy Holdings Corp. announced it received an allowance from the Japan Patent Office for its solid-state battery technology patent application, marking its first patent approval in Japan. This patent covers key innovations in powderized solid-state electrolyte and electroactive materials critical to the company's dry electrode manufactur…
TransUnion has introduced Digital Business Profile, a new affordable solution enabling small businesses to manage and maintain consistent business information across over 80 digital directories, maps, apps, and social platforms through a single portal. This service addresses the growing complexity of maintaining accurate online data in the AI-power…
Primech Holdings Limited, through its subsidiary Primech AI, is accelerating its U.S. expansion by participating in the SelectUSA Tech program and the 2026 SelectUSA Investment Summit. The company aims to capitalize on increasing demand for its AI-powered autonomous restroom cleaning robot, Hytron, in the U.S. market, particularly targeting healthc…
urban-gro, Inc. (Nasdaq: UGRO), through its subsidiary Innovative Production Group (IPG), will participate in the Lanka Premier League (LPL) Season 6 scheduled from July 10 to August 5, 2026, across four Sri Lankan venues. This engagement represents the first full season following urban-gro's integration with Flash Sports & Media and IPG, leveragin…
The Joint Corp., the largest franchisor of chiropractic care clinics in the U.S., announced it will release its first quarter 2026 financial results on May 7 after market close, followed by a live webcast and conference call presenting the company's performance and business update.
Ocugen, Inc., a biotechnology company focusing on gene therapies for blindness diseases, announced that its executives will present at two prominent biotech conferences in April 2026. The presentations will cover their novel modifier gene therapy platform and near-term catalysts, including the planned Biologics License Application (BLA) submission …
Altisource Portfolio Solutions S.A. announced its Q1 2026 financial results, highlighting a 10% increase in service revenue to $45.1 million, substantial improvements in pretax earnings and operating cash flow compared to Q1 2025. The Origination segment saw a 71% growth in service revenue and a 166% increase in adjusted EBITDA, fueled by sales win…
Nasdaq, Inc. announced a raised quarterly dividend of $0.31 per share, payable on June 26, 2026. This dividend increase reflects Nasdaq's strong financial position and commitment to returning value to shareholders. The company continues to focus on powering global markets through advanced technology and data solutions.
Purple Biotech announced the establishment of a Scientific Advisory Board (SAB) comprising leading experts in T-cell and NK cell engager therapies and tumor immunology. The SAB will advise the company on the development of its CAPTN-3 tri-specific antibody platform aimed at maximizing anti-cancer efficacy while minimizing toxicity by activating imm…
Nasdaq, Inc. reported strong financial results for Q1 2026, delivering 14% net revenue growth to $1.4 billion and 33% GAAP diluted earnings per share growth year-over-year. All business divisions—Financial Technology, Capital Access Platforms, and Market Services—showed robust organic growth, driven by increased client adoption, expansion of AI-dri…
Valley National Bancorp reported first quarter 2026 net income of $163.9 million, or $0.28 per diluted common share, reflecting a solid financial performance with a 5.5% annualized loan growth and increased deposit balances. The bank maintained a stable net interest margin of 3.17% and continued to diversify its loan portfolio while investing in AI…
BrewDog USA, part of Tilray Brands, announced a strong lineup of core craft beers and new non-alcoholic beverages aimed at expanding its market presence across the U.S. The company is focusing on innovation-led growth with enhanced marketing campaigns for flagship IPAs like Elvis Juice along with launching a new non-alcoholic Juiced Club series. Br…
ConnectOne Bancorp, Inc. reported robust first quarter 2026 financial results characterized by a 12 basis point increase in net interest margin to 3.39%, 10% annualized loan and deposit growth, and an 8.3% increase in common stock dividend per share. The merger with First of Long Island Corporation continues to contribute positively to earnings, as…
Malibu Boats, Inc. will release its third quarter fiscal 2026 financial results on May 7, 2026, after market close, followed by a management conference call. The call will be hosted by CEO Steve Menneto and CFO David Black, providing insights into the company's performance. Malibu Boats is a leading manufacturer of recreational powerboats, includin…
Tonix Pharmaceuticals presented preclinical data demonstrating that its TNX-1700 (a TFF2-albumin fusion protein) effectively reverses aging-associated gastric inflammation and reduces tumor progression, while TNX-4700 (anti-BTLA monoclonal antibody) showed potent binding and functional antagonism. These developments highlight Tonix's advancing immu…
American Airlines Group Inc. reported a record first-quarter revenue of $13.9 billion in 2026, marking a 10.8% year-over-year increase. The company reduced its total debt to $34.7 billion, the lowest since mid-2015. Despite a GAAP net loss of $382 million due to increased fuel costs, underlying performance improved with a reduced loss excluding spe…
Aeluma, Inc., a US-based semiconductor company focusing on high-performance scalable technologies, announced its participation in the 2026 SPIE Defense + Security Conference. The company will exhibit its disruptive photonic and electronic semiconductor products, highlighting innovations in shortwave infrared sensors and quantum dot lasers. The even…
B2Gold Corp. has finalized the sale of its 70% interest in Fingold Ventures Ltd. to Agnico Eagle Mines Limited for $325 million in cash. The company expresses eagerness to collaborate with Agnico Eagle in Nunavut, Canada under a new collaboration agreement, aiming to share expertise and operational best practices.
Descartes Systems Group has acquired Idelic, a provider of AI-powered driver safety and performance management solutions. This acquisition integrates Idelic's extensive safety data and predictive analytics capabilities into Descartes' Global Logistics Network, enhancing fleet safety and operational efficiency. The deal includes an upfront $28 milli…
Pool Corporation reported a 6% increase in net sales driven by resilient maintenance product demand and equipment sales, with operating income up 7% in Q1 2026. The company confirmed its annual earnings guidance range of $10.87 to $11.17 per diluted share. Gross margins were slightly down due to seasonal mix and early buy purchases, but operating m…
Psyence Biomedical Ltd. (Nasdaq: PBM) has initiated patient dosing in its Phase IIb clinical trial evaluating NPX-5, a nature-derived psilocybin, for treating Adjustment Disorder in cancer patients undergoing palliative care. The randomized, double-blind trial is conducted across five Australian clinical sites aiming to assess safety, efficacy, and…
Jade Biosciences announced the grant of a non-qualified stock option award for 500,000 shares to Dr. Edward R. Conner, newly appointed Chief Medical Officer. The award was made under the company's Inducement Plan, complying with Nasdaq Listing Rule 5635(c)(4), with options priced at the closing market value of $25.38 per share and vesting over four…
Radiopharm Theranostics provided a business update highlighting completion of enrollment in a Phase 2b trial of RAD 101 with promising 90% concordance to MRI. Positive early Phase 0/1 data for RAD 202 was presented with a recommendation to escalate dosing. Two first-in-human trials were initiated for RV-01 and RAD 402 targeting multiple cancers. Fi…
